## Hi there ğŸ‘‹

<!--
ğŸ‘‹ I am a molecular biologist turned computational genomic scientist with 5+ years of experience analyzing next-generation sequencing data with expertise in melanoma, neurodegenerative disease, epigenetics, and RNA biology. 

ğŸ“ I earned my PhD in Genetics & Genomics from Boston University School of Medicine where I discovered the role of the CoREST epigenetic complex in RNA splicing and developed a method to resensitize immunotherapy-resistant tumors to immune checkpoint blockade.

ğŸ§¬ I was a Computational Genomics Intern at ReviR Therapeutics, an early stage RNA therapeutics company, where I spearheaded a computational pipeline to automate RNA splicing small molecule characterization and integrated it into an in-house data user interface for wet lab biology use. I also created a machine learning model trained on large-scale informatic datasets to predict nonsense-mediated decay induced by RNA splicing small molecules.

ğŸ“šPublications:
	- CoREST Complex Inhibition Alters RNA Splicing to Promote Neoantigen Expression and Enhance Tumor Immunity 
	- The CoREST Repressor Complex Mediates Phenotype Switching and Therapy Resistance in Melanoma
	- Targeting of the CoREST Repressor Complex in Atypical Teratoid Rhabdoid Tumors Restores Epigenetic Balance and Unlocks Irreversible Differentiation Programs
	- The CoREST complex is a therapeutic vulnerability in malignant peripheral nerve sheath tumors
	- Epigenetics and Cutaneous Neoplasms: From Mechanism to Therapy
 
ğŸ“« How to reach me: 
  - Email: rjfisher002@gmail.com
-->
